Sign Up Today and Learn More About Unobravo | Telehealth & psychology Stock

Invest in or calculate the value of your shares in Unobravo | Telehealth & psychology or other pre-IPO companies through EquityZen's platform.

Get Started

Unobravo | Telehealth & psychology Stock

Unobravo is a platform that matches people looking for psychological support with the therapist best suited to support them.

About Unobravo | Telehealth & psychology Stock

Founded

2019

Unobravo is a platform that matches people looking for psychological support with the therapist best suited to support them, facilitates the therapy journey via video calls, and helps therapists run their practices more efficiently. The therapists we work with are all licensed psychologists and are carefully selected by our team. Our matching algorithm is deeply rooted in the clinical experience of our team and takes into account on one hand the clinical need and personal preferences of the patient, and on the other the expertise of the therapist. Unobravo was founded in 2019. In July 2023 it counts 2500+ therapists, 80.000+ patients and over a million therapy sessions. Unobravo leads Italian market and is scaling up the Spanish one (under the brand "Buencoco").

Unobravo | Telehealth & psychology Management

Leadership team at Unobravo | Telehealth & psychology

MD Product

Erica Bigi

Angel Investor

Andrea D'Aietti

Locked Features

Join now and verify your accreditation status to gain access to:

  • Unobravo | Telehealth & psychology current valuation
  • Unobravo | Telehealth & psychology stock price
  • Available deals in Unobravo | Telehealth & psychology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Unobravo | Telehealth & psychology stock?

Accredited investors can buy pre-IPO stock in companies like Unobravo | Telehealth & psychology through EquityZen funds. These investments are made available by existing Unobravo | Telehealth & psychology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Unobravo | Telehealth & psychology stock?

Shareholders can sell their Unobravo | Telehealth & psychology stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."